The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]
Enable Injections
Enable Injections completes $25M credit facility
Enable Injections announced today that it completed a credit facility worth $25 million from Oxford Finance LLC. Cincinnati-based Enable Injections said in a news release that the funds are earmarked for supporting the scaling of high-volume manufacturing and the achievement of major inflection points as it moves toward commercialization. The company develops the enFuse, a […]
Enable Injections inks deal with Genentech
Enable Injections said yesterday that it entered a developmental partnership with Genentech for the Enable enFuse device. Cincinnati-based Enable’s enFuse is an on-body drug delivery platform containing a drug transfer system compatible with syringes and vial containers. Currently, the enFuse is being developed for subcutaneous delivery of large volumes potentially rising to 50 mL. The […]
Enable Injections inks deal with Sanofi for drug delivery platform
Enable Injections said today that it inked a partnership with Sanofi for its enFuse drug delivery platform. Cincinnati-based Enable Injections developed the enFuse device to enable patient-administered subcutaneous delivery of high-volume therapeutics outside of the hospital. The on-body drug delivery platform has a self-contained drug transfer system that is compatible with standard syringes and vial […]
Enable Injections inks development deals for wearable drug-delivery device
Enable Injections said today that it inked development deals with Apellis Pharmaceuticals and UCB for its enFuse on-body drug-delivery device. The Cincinnati-based company has ongoing partnerships with five companies. Enable Injection’s enFuse device is designed for the subcutaneous delivery of high-volume drugs, including monoclonal antibodies. “Because enFuse frees patients to self-administer at home, it greatly […]
Sanofi leads $50m round for Enable Injections’ on-body drug-delivery platform
Enable Injections said last week that it closed a $50 million Series B round, led by Sanofi (NYSE:SNY), to fund the development of its enFuse on-body drug-delivery system. Previous investors, including the Cleveland Clinic and CincyTech, and private investors also participated in the round. Enable Injections has developed a drug-delivery device that’s designed to deliver doses […]
How Enable Injections plans to bring value to pharma with its drug-delivery device
Mike Hooven is no stranger to the medical device industry – he has spent the last 30 years launching companies and developing technologies for a variety of clinical applications. So when he ventured into drug delivery, he knew that he needed to find out what people in the pharmaceutical industry needed. A number of executives […]
Meet 5 companies developing novel drug-delivery devices
At the 7th annual Partnership Opportunities in Drug Delivery event, presented by The Conference Forum, device companies gathered to tout their drug-delivery technologies and learn from each other’s mistakes and successes. Among them were needle-free injectors, patch pumps, auto-injectors and other novel delivery devices. Moderated by Pfizer‘s (NYSE:PFE) senior director of device strategy, Mathias Romacker, […]
Enable Injections launches multi-vial/syringe biologics delivery system
Enable Injections Inc. launched a new single, partial or multi-vial/syringe transfer system used to fill its large volume wearable injectors. The system enables patients to either use multiple vials or syringes to deliver biologics and high volume drugs subcutaneously. The hand-held transfer system can work with any pharmaceutical primary container closure, Enable Injections said, and […]
Enable Injections lands $30m Series A for large-volume injector
Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s body and delivers biologic doses as large as 50 milliliters. It can be used at work or at home, providing an alternative to costly […]
